The inhibitory effects of deep-sea water on doxorubicin‑induced epithelial-mesenchymal transition.

Abstract:

:It has been revealed that the induction of epithelial‑mesenchymal transition (EMT) is associated with drug resistance, leading to tumor recurrence and metastasis. Recent studies have shown that chemotherapeutic agents, besides their therapeutic effects, can induce EMT and enhance invasive and metastatic properties of tumor cells. Previously, we revealed that deep-sea water (DSW) exhibited antimetastatic effects in several human cancer cell lines. In the present study, we investigated the effects of DSW on doxorubicin-induced EMT in MCF-7 human breast cancer cells. When treated with doxorubicin, MCF-7 cells displayed characteristics of EMT, such as, mesenchymal markers (vimentin and fibronectin) and EMT-related transcription factors (Slug and Snail-1) in their RNA expression. However, DSW efficiently inhibited doxorubicin-induced EMT, revealing the decreased expression of vimentin, fibronectin, Slug and Snail-1. Moreover, treatment of MCF-7 cells with DSW significantly suppressed their increased migratory ability by doxorubicin as determined by wound-healing assay. We further demonstrated that the inhibitory effects of DSW on doxorubicin-induced EMT appeared to be mediated by inhibition of the ERK1/2, p38 MAPK and PI3K/AKT signaling pathways. Collectively, our data revealed that DSW has the potential to abolish undesired side-effects of doxorubicin by targeting EMT.

journal_name

Oncol Rep

journal_title

Oncology reports

authors

Chun SY,Kim S,Nam KS

doi

10.3892/or.2017.5726

subject

Has Abstract

pub_date

2017-08-01 00:00:00

pages

1163-1171

issue

2

eissn

1021-335X

issn

1791-2431

journal_volume

38

pub_type

杂志文章
  • Expression and activation of P38 MAP kinase in invasive ductal breast cancers: correlation with expression of the estrogen receptor, HER2 and downstream signaling phosphorylated proteins.

    abstract::MAP kinase signaling proteins have major implications in the molecular oncogenesis of breast cancers and have been extensively investigated as putative targets for therapy. This study reports the investigation of the expression of P38 MAPK and its phosphorylated form (p-P38 MAPK) in clinical specimens of invasive brea...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2645

    authors: Merlin JL,Harlé A,Lion M,Ramacci C,Leroux A

    更新日期:2013-10-01 00:00:00

  • DAL-1 attenuates epithelial to mesenchymal transition and metastasis by suppressing HSPA5 expression in non-small cell lung cancer.

    abstract::Metastasis is the primary cause of death in lung cancer patients and EMT (epithelial-mesenchymal transition) promotes metastasis. Previous study revealed that DAL-1 (differentially expressed in adenocarcinoma of the lung) could attenuate EMT and metastasis in non-small cell lung cancer (NSCLC). Further study proved th...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.6000

    authors: Qiu X,Guan X,Liu W,Zhang Y

    更新日期:2017-11-01 00:00:00

  • Fingolimod sensitizes EGFR wild‑type non‑small cell lung cancer cells to lapatinib or sorafenib and induces cell cycle arrest.

    abstract::Epidermal growth factor receptor (EGFR) is a receptor tyrosine kinase and mutations in this gene are major drivers of lung cancer development. EGFR tyrosine kinase inhibitors (TKIs) are standard first‑line therapies for patients with advanced non‑small cell lung cancer (NSCLC) with activating EGFR mutations, but are n...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7140

    authors: Ota K,Okuma T,Lorenzo A,Yokota A,Hino H,Kazama H,Moriya S,Takano N,Hiramoto M,Miyazawa K

    更新日期:2019-07-01 00:00:00

  • CRISPR/Cas9-mediated genome engineering of CXCR4 decreases the malignancy of hepatocellular carcinoma cells in vitro and in vivo.

    abstract::CXC chemokine receptor 4 (CXCR4) is associated with poor clinical outcomes and decreased survival in hepatocellular carcinoma (HCC). In the present study, we targeted CXCR4 by CRISPR/Cas9 in HepG2 cells and observed the effects both in vitro and in vivo. The results indicated that after targeting CXCR4 the expression ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5601

    authors: Wang X,Zhang W,Ding Y,Guo X,Yuan Y,Li D

    更新日期:2017-06-01 00:00:00

  • Significance of Lysyl oxidase‑like 2 gene expression on the epithelial‑mesenchymal status of hepatocellular carcinoma.

    abstract::In the present study, we investigated the role of lysyl oxidase‑like 2 (LOXL2), the correlation between LOXL2 and epithelial to mesenchymal transition (EMT) and the effects of using β‑aminopropionitrile (BAPN) to inhibit LOXL2 with the aim of reducing tumor progression in hepatocellular carcinoma (HCC). The expression...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6349

    authors: Ninomiya G,Yamada S,Hayashi M,Takeda S,Suenaga M,Takami H,Kanda M,Iwata N,Niwa Y,Tanaka C,Kobayashi D,Fujii T,Nakayama G,Sugimoto H,Koike M,Fujiwara M,Kodera Y

    更新日期:2018-06-01 00:00:00

  • Association between mitochondrial DNA 4,977 bp deletion and NAD(P)H:quinone oxidoreductase 1 C609T polymorphism in human breast tissues.

    abstract::The NAD(P)H:quinone oxidoreductase 1 (NQO1) enzyme is implicated in protection against oxidative stress and carcinogenesis. NQO1 C609T genetic polymorphism was reported to be associated with an increased risk for cancers, including breast cancer. However, there is still lack of evidence whether higher oxidative stress...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000337

    authors: Tseng LM,Yin PH,Tsai YF,Chi CW,Wu CW,Lee LM,Lee HC

    更新日期:2009-05-01 00:00:00

  • The usefulness and limits of magnetic resonance imaging in the differential diagnosis of pelvic tumors.

    abstract::Three cases of benign pelvic tumors are presented (2 leiomyomas and 1 fibroma). All three tumors were suspected of being malignant neoplasms because they were visualized as heterogeneous high signal intensity on T2-weighted images, and thus they were difficult to diagnose preoperatively. One of the leiomyomas was loca...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.8.4.867

    authors: Kojima T,Ishiko O,Ichimura T,Nishimura S,Sumi T,Ueda J,Tsujimura T,Shimura K

    更新日期:2001-07-01 00:00:00

  • The newly synthesized 2-(3-hydroxy-5-methoxyphenyl)-6,7-methylenedioxyquinolin-4-one triggers cell apoptosis through induction of oxidative stress and upregulation of the p38 MAPK signaling pathway in HL-60 human leukemia cells.

    abstract::The aim of the present study was to discover the signaling pathways associated with 2-(3-hydroxy-5-methoxy-phenyl)-6,7-methylenedioxyquinolin-4-one (YYK1)-induced apoptosis in HL-60 human leukemia cells. YYK1 induced cytotoxic effects, cell morphological changes, decreased the cell ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1923

    authors: Cheng YY,Yang JS,Tsai SC,Liaw CC,Chung JG,Huang LJ,Lee KH,Lu CC,Chien HC,Tsuzuki M,Kuo SC

    更新日期:2012-10-01 00:00:00

  • Human DNA topoisomerase II-alpha expression in laparoscopically treated renal cell carcinoma.

    abstract::To investigate whether the expression of Topoisomerase II-alpha (TII-alpha) can serve as a prognostic factor in renal cell carcinoma (RCC), histological sections from 27 renal tumors were stained immunohistochemically for TII-alpha expression. The percentage of positive cells in the area of greatest staining was recor...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Dekel Y,Frede T,Kugel V,Neumann G,Rassweiler J,Koren R

    更新日期:2005-07-01 00:00:00

  • MicroRNA‑203a‑3p is a candidate tumor suppressor that targets thrombospondin 2 in colorectal carcinoma.

    abstract::The aim of the present study was to investigate the role of miR‑203a‑3p in colorectal cancer (CRC) and identify the target gene of microRNA (miR)‑203a‑3p. A total of 59 sets of cancer tissues and corresponding adjacent non‑tumor tissues were collected from CRC patients (aged 31‑78 years) between October 2016 and May 2...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7310

    authors: Qian Z,Gong L,Mou Y,Han Y,Zheng S

    更新日期:2019-11-01 00:00:00

  • Clinicoprognostical features of endometrial cancer patients with somatic mtDNA mutations.

    abstract::Somatic mitochondrial DNA (mtDNA) mutations have been found in a subset of endometrial cancers (EC) from different populations. We have investigated the relationship between mtDNA changes and clinical and pathological variables of women affected by EC. mtDNA mutations were detected both in early (3/32; 9%) and in adva...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Semczuk A,Lorenc A,Putowski L,Futyma K,Bryk J,Miotla P,Bartnik E

    更新日期:2006-11-01 00:00:00

  • miR-367 promotes tumor growth by inhibiting FBXW7 in NSCLC.

    abstract::miR-367 is one of the most abundant miRNAs in human embryonic stem cells (hESCs) and is mainly involved in maintaining the pluripotency of stem cells. However, its role in cancer development remains poorly understood. In the present study, we explored the function and mechanism of the endogenous miR-367 in non-small c...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2017.5755

    authors: Xiao G,Gao X,Sun X,Yang C,Zhang B,Sun R,Huang G,Li X,Liu J,Du N,Liu D,Liang R,Ren H,Qin S

    更新日期:2017-08-01 00:00:00

  • Gene module analysis of juvenile myelomonocytic leukemia and screening of anticancer drugs.

    abstract::Juvenile myelomonocytic leukemia (JMML) is a rare but severe primary hemopoietic system tumor of childhood, most frequent in children 4 years and younger. There are currently no specific anticancer therapies targeting JMML, and the underlying gene expression changes have not been revealed. To define molecular targets ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2018.6709

    authors: Zhao W,Wang L,Yu Y

    更新日期:2018-12-01 00:00:00

  • TGF‑β1‑induced epithelial‑mesenchymal transition increases fatty acid oxidation and OXPHOS activity via the p‑AMPK pathway in breast cancer cells.

    abstract::Breast cancer is the most common malignancy in women, and metastasis is the leading cause of death in breast cancer patients. Previous studies have shown that epithelial‑mesenchymal transition (EMT) is involved in the metastasis of breast cancer, but the metabolic reprogramming and regulation mechanisms involved in th...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7661

    authors: Liu QQ,Huo HY,Ao S,Liu T,Yang L,Fei ZY,Zhang ZQ,Ding L,Cui QH,Lin J,Yu M,Xiong W

    更新日期:2020-09-01 00:00:00

  • Roles of the HGF/Met signaling in head and neck squamous cell carcinoma: Focus on tumor immunity (Review).

    abstract::c‑mesenchymal‑epithelial transition (Met) is a transmembrane tyrosine kinase receptor of hepatocyte growth factor (HGF). HGF/Met signaling stimulates numerous pathways, including the Ras/mitogenactivated protein kinase (MAPK), phosphatidylinositol 3‑kinase/protein kinase B and Wnt/β‑catenin pathways, which serve impor...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2020.7799

    authors: Liu D,Zhong M,Zhan D,Zhang Y,Liu S

    更新日期:2020-12-01 00:00:00

  • Pancreatic tumor mass in a xenograft mouse model is decreased by treatment with therapeutic stem cells following introduction of therapeutic genes.

    abstract::Pancreatic cancer is the fourth most common cause of cancer-related mortality. In the present study, we employed 2 types of therapeutic stem cells expressing cytosine deaminase (CD) with or without human interferon-β (IFN‑β), HB1.F3.CD and HB1.F3.CD.IFN-β cells, respectively, to selectively treat pancreatic cancer. Th...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2013.2564

    authors: Kim DJ,Yi BR,Lee HR,Kim SU,Choi KC

    更新日期:2013-09-01 00:00:00

  • Identification of prognostic microRNA candidates for head and neck squamous cell carcinoma.

    abstract::The aim of the present study was to uncover potential prognostic microRNA (miRNA) markers in head and neck squamous cell carcinoma (HNSCC). miRNA expression profile and clinical data were obtained from The Cancer Genome Atlas (TCGA) database. Survival analysis was conducted by Kaplan-Meier method. Then, candidate prog...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2016.4698

    authors: Hui L,Wu H,Yang N,Guo X,Jang X

    更新日期:2016-06-01 00:00:00

  • Decomposition of dextran sulfate sodium under alkaline, acidic, high temperature and high pressure conditions.

    abstract::The pathogenic mechanisms responsible for inflammatory bowel disease (IBD) are poorly understood. In an IBD animal model, the oral administration of polysaccharides such as dextran sulfate sodium (DSS) induced colitis, which exhibited several clinical and histological features similar to IBD. However, pathogenic facto...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Araki Y,Mukaisyo K,Sugihara H,Hattori T

    更新日期:2008-07-01 00:00:00

  • Pathomorphological study on small nodular lesions in hepatitis C virus-related cirrhosis.

    abstract::We examined pathomorphologically small nodular lesions in hepatitis C virus-related cirrhosis (type C cirrhosis). Small nodular lesions seen in the non-cancerous areas of 128 consecutively resected hepatocellular carcinomas (HCCs) associated with type C cirrhosis were selected for the study. From these, 18 large regen...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Miyaaki H,Fujimoto M,Kurogi M,Nakashima O,Eguchi K,Kojiro M

    更新日期:2005-12-01 00:00:00

  • Role of diffusion-weighted imaging in evaluating therapeutic efficacy after transcatheter arterial chemoembolization for hepatocellular carcinoma.

    abstract::The decision to repeat transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) is based on correct evaluation of response to therapy. The purpose of this study was to investigate whether apparent diffusion coefficient (ADC), a quantitative parameter of diffusion-weighted imaging (DWI), can p...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or_00000914

    authors: Kubota K,Yamanishi T,Itoh S,Murata Y,Miyatake K,Yasunami H,Morio K,Hamada N,Nishioka A,Ogawa Y

    更新日期:2010-09-01 00:00:00

  • Trastuzumab and docetaxel in a preclinical organotypic breast cancer model using tissue slices from mammary fat pad: Translational relevance.

    abstract::With the ever-increasing number of drugs approved to treat cancers, selection of the optimal treatment regimen for an individual patient is challenging. Breast cancer complexity requires novel predictive methods and tools. In the present study, we set up experimental conditions to obtain an 'ex vivo' organotypic cultu...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2015.4074

    authors: Vesci L,Carollo V,Roscilli G,Aurisicchio L,Ferrara FF,Spagnoli L,De Santis R

    更新日期:2015-09-01 00:00:00

  • 5-Lipoxygenase inhibitors attenuate growth of human renal cell carcinoma and induce apoptosis through arachidonic acid pathway.

    abstract::The metabolism of arachidonic acid by either the cyclooxygenase or lipoxygenase (LOX) pathway is believed to play an important role in tumor promotion. We investigated the expression of 5- and 12-LOX in renal cell carcinoma (RCC), as well as the effects of their inhibitors on cell proliferation in 2 RCC cell lines (Ca...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Matsuyama M,Yoshimura R,Mitsuhashi M,Tsuchida K,Takemoto Y,Kawahito Y,Sano H,Nakatani T

    更新日期:2005-07-01 00:00:00

  • Ku80 gene knockdown by the CRISPR/Cas9 technique affects the biological functions of human thyroid carcinoma cells.

    abstract::In the present study, to evaluate the role of Ku80 in thyroid carcinoma (TC), 86 thyroid tissue samples from patients with a spectrum of thyroid disorders were examined for protein levels of Ku80, nuclear factor‑κB (NF‑κB) and RET/TC by immunohistochemistry. Furthermore, in TC cells, Ku80 mRNA was detected by reverse ...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2019.7348

    authors: Fan Y,Li J,Wei W,Fang H,Duan Y,Li N,Zhang Y,Yu J,Wang J

    更新日期:2019-12-01 00:00:00

  • Low dose carboplatin (AUC 4.5) combined with vinorelbine in the treatment of advanced non-small cell lung cancer: a single institution phase II study.

    abstract::Platinum compounds and vinorelbine (VNB) are active in the treatment of non-small cell lung cancer (NSCLC), but moderate toxicity has been reported. The aims of the present study were to assess activity and tolerability of low dose carboplatin (CBDCA): 4.5 AUC according to Calvert formula on day 1, combined with vinor...

    journal_title:Oncology reports

    pub_type: 临床试验,杂志文章

    doi:10.3892/or.8.2.381

    authors: Bretti S,Manzin E,Celano A,Ritorto G,Loddo C,Berruti A

    更新日期:2001-03-01 00:00:00

  • 3,3'-Diindolylmethane suppresses growth of human esophageal squamous cancer cells by G1 cell cycle arrest.

    abstract::3,3'-Diindolylmethane (DIM), an active metabolite of indole-3-carbinol, is thought to have antitumor effects in experimental animals and induce apoptosis in various cancer cells. However, the biological functions of DIM in human esophageal cancer cells are unknown. Thus, the purpose...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:10.3892/or.2012.1662

    authors: Kim SJ,Lee JS,Kim SM

    更新日期:2012-05-01 00:00:00

  • Overexpression of orotate phosphoribosyl transferase in hormone-refractory prostate cancer.

    abstract::Orotate phosphoribosyl transferase (OPRT) is the initial enzyme of 5-fluorouracil (5-FU) activation, in which 5-FU is converted to 5-fluorouridinemonophosphate. Dihydropyrimidine dehydrogenase (DPD) is a degrading enzyme that catabolizes 5-FU. In this study, we investigated the expression of these enzymes in normal pr...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Tanaka T,Kawashima H,Matsumura K,Yamashita-Hosono T,Yoshimura R,Kuratsukuri K,Harimoto K,Nakatani T

    更新日期:2009-01-01 00:00:00

  • Frequent CYP1A1 expression in gastric cancers and their related lesions.

    abstract::CYP1A1 expression in various tissues of 43 gastric cancer cases was analyzed with frozen tissue array-based immunohistochemical staining (IHC), RT-PCR, Western blot analysis and EROD (7-ethoxyresourfin-O-deethylase) assay. CYP1A1 was detected immunohistochemically in 86% (37/43) of gastric cancers, in both 57% (4/7) o...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Zhang KL,Ma JX,Chen XY,Sun Y,Kong QY,Liu J,Li H

    更新日期:2004-12-01 00:00:00

  • Treatment with HER-2 phosphorylation agonists enhance tumor ability to stimulate epitope specific CTL in vitro.

    abstract::The transmembrane (TM) receptor encoded by the HER-2 proto-oncogene (HER-2) is amplified in several types of human carcinomas and premalignant states and provides an important target for cancer therapy. While overexpression of HER-2 should lead to increased CTL epitope formation due to the attendant increase in higher...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Castilleja A,Ward NE,Epstein RB,Kudelka AP,Gershenson DM,Efferson CL,O'Brian CA,Ioannides CG

    更新日期:2002-09-01 00:00:00

  • Pharmacological inhibition of Rho-kinase signaling with Y-27632 blocks melanoma tumor growth.

    abstract::Primarily through in vitro studies, the Rho-family of small GTPases and their effector proteins have been implicated in mediating oncogenic properties of cancer cells. We sought to determine if pharmacological inhibition of the RhoA effector proteins known as Rho-kinases (ROCK) with the small molecule inhibitor Y-2763...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Routhier A,Astuccio M,Lahey D,Monfredo N,Johnson A,Callahan W,Partington A,Fellows K,Ouellette L,Zhidro S,Goodrow C,Smith A,Sullivan K,Simone P,Le L,Vezuli B,Zohni M,West E,Gleason D,Bryan B

    更新日期:2010-03-01 00:00:00

  • The hTERT protein as a marker for malignancy in meningiomas.

    abstract::The meningioma evolution remains problematic as 6 to 19% relapse after total resection. We have no criterion or marker to predict with certainty the tumour behaviour, and the WHO grading system is to a certain degree controversial. Telomerase expression seems to play an active role in conferring to the tumour cell ind...

    journal_title:Oncology reports

    pub_type: 杂志文章

    doi:

    authors: Kalala JP,Maes L,Vandenbroecke C,de Ridder L

    更新日期:2005-02-01 00:00:00